Development of treatment strategies to combat Ebola and Marburg viruses
- 1 February 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 4 (1) , 67-76
- https://doi.org/10.1586/14787210.4.1.67
Abstract
Ebola and Marburg viruses are emerging/re-emerging pathogens that pose a significant threat to human health. These naturally occurring viral infections frequently cause a lethal hemorrhagic fever in humans and nonhuman primates. The disastrous consequences of infection with these viruses have been pursued as potential biological weapons. To date, there are no therapeutic options available for the prophylaxis or treatment of infected individuals. The recognition that Ebola and Marburg viruses may be exploited as biological weapons has resulted in major efforts to develop modalities to counter infection. In this review, select technologies and approaches will be highlighted as part of the critical path for the development of therapeutics to ameliorate the invariably devastating outcomes of human filoviral infections.Keywords
This publication has 83 references indexed in Scilit:
- Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesNature Medicine, 2005
- Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screeningVirology, 2005
- Rescue of Ebola virus from cDNA using heterologous support proteinsVirus Research, 2004
- Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus MacaquesThe American Journal of Pathology, 2003
- Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primatesNature, 2003
- Reverse Genetics Demonstrates that Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Essential for Replication in Cell CultureJournal of Virology, 2002
- Recovery of Infectious Ebola Virus from Complementary DNA: RNA Editing of the GP Gene and Viral CytotoxicityScience, 2001
- Development of a preventive vaccine for Ebola virus infection in primatesNature, 2000
- Organization of Patient Care during the Ebola Hemorrhagic Fever Epidemic in Kikwit, Democratic Republic of the Congo, 1995The Journal of Infectious Diseases, 1999
- Negative-pressure plastic isolator for patients with dangerous infections.BMJ, 1977